about
Cytotoxicity of purified listeriolysin O on mouse and human leukocytes and leukaemia cellsCytotoxicity of bacterial metabolic products, including listeriolysin O, on leukocyte targets.Rituximab, cladribine and cyclophosphamide (RCC) induction with rituximab maintenance in chronic lymphocytic leukemia: PALG - CLL4 (ML21283) trial.Microenvironment-induced PIM kinases promote CXCR4-triggered mTOR pathway required for chronic lymphocytic leukaemia cell migration.Increased expression of E3 ubiquitin ligases targeting p53 in CLL patients with wild-type TP53 exhibits associations with clinical features of the disease.Atypical chronic myeloid leukaemia: A case of an orphan disease-A multicenter report by the Polish Adult Leukemia GroupTreatment of elderly patients with acute myeloid leukemia adjusted for performance status and presence of comorbidities: a Polish Adult Leukemia Group studyComparable Efficacy of Idelalisib Plus Rituximab and Ibrutinib in Relapsed/refractory Chronic Lymphocytic Leukemia: A Retrospective Case Matched Study of the Polish Adult Leukemia Group (PALG)
P50
Q35227459-54B73B99-BC30-4C9A-9B2E-AE9CC8CFDF49Q39254666-772BEDFC-C9B4-4C50-823D-BA587C8AF1AEQ50088468-706DE693-E31D-4479-B949-2120088D161FQ52582842-0349622A-C90B-4267-988A-C5F0E5B8EDF1Q53329470-6D90C36E-C14A-4922-AAF4-6446B39BD718Q60488093-69C68981-7837-4BCD-BF2B-75A8830DA5CAQ85956565-E53F63DB-4C69-4369-94CF-DEC4B86AEF25Q88531394-643B1444-ED8F-44CE-B79B-98E4E571F247
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
B K Budziszewska
@en
B K Budziszewska
@nl
type
label
B K Budziszewska
@en
B K Budziszewska
@nl
prefLabel
B K Budziszewska
@en
B K Budziszewska
@nl
P31
P496
0000-0002-9482-4099